Breast Cancer Clinical Trials

Find Breast Cancer Clinical Trials Near You

Studying the Role of Circulating Tumor Cell Clusters in Patients With High-risk Early Breast Cancer, Study GALIA

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

CTCs, CTC clusters, and ctDNA may predict treatment response and survival in high-risk breast cancer, including IBC.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients with inflammatory breast cancer, regardless of cancer subtype (stage IIID)

• Patients with non-inflammatory breast cancer: triple-negative and HER2+ subtypes, from stage IIB to IIIA-C

• Adequate health status for neoadjuvant systemic treatment

Locations
Other Locations
Slovenia
Institute of Oncology Ljubljana
RECRUITING
Ljubljana
Contact Information
Primary
Klavdija Korošec
kkorosec@onko-i.si
00386 1 5879 639
Backup
Neza Gros
ngros@onko-i.si
00386 1 5879 014
Time Frame
Start Date: 2024-02-07
Estimated Completion Date: 2028-12-31
Participants
Target number of participants: 130
Treatments
Other: High risk breast cancer patients
Adult women with inflammatory breast cancer (stage IIID) and non-inflammatory triple negative and HER2+ subtype (stage IIB to IIIA-C) with adequate health status for neoadjuvant systemic treatment
Related Therapeutic Areas
Sponsors
Leads: Institute of Oncology Ljubljana

This content was sourced from clinicaltrials.gov